To confirm the potentially protective role of TRIM21 in the pathogenesis of steatosis and related metabolic disorders, we used an adenoviral approach to achieve TRIM21 overexpression in mouse liver in vivo. This evidence concerns the gene TRIM21 and Other metabolic disease.